HSP90AA1 and colorectal cancer: It has been previously demonstrated that Hsp90 promotes EMT in colorectal cancer via activation of HIF-1α, which results in a subsequent downregulation of Hsp90, leading to inhibition of EMT, motility, and invasiveness [29, 30].